Search
for
Sort by
Research 871–900 of 1000+
- Baricitinib: A Review in Severe Alopecia Areata
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Oral Baricitinib Restores Hair Loss in Alopecia Areata
- Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
- Alopecia universalis. Partial response to tofacitinib
- One of the best treatments for alopecia areata remains unpublished
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Alopecia Areata: Current and Emerging Therapies
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- S3‐Leitlinie Diagnostik und Therapie der Alopecia areata – Teil 2: Therapie, psychosoziale und kosmetische Unterstützung
- When hair dig into the brain, JAKi , may help!
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Assessment and treatment of adolescent hair loss
- HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology